Hepatitis E Diagnostic Tests Market to Reach USD 78.62 Million by 2032, Growing at 4.6% CAGR: Polaris Market Research

According to a new report by Polaris Market Research, the global Hepatitis E diagnostic tests market was valued at USD 54.61 million in 2024 and is projected to reach USD 78.62 million by 2032, expanding at a CAGR of 4.6% over the forecast period. Growth is underpinned by the rising incidence of Hepatitis E, expanding adoption of molecular diagnostics, and accelerating investment in point-of-care testing across key end-use settings.

What Is Driving Hepatitis E Diagnostic Tests Market Growth?

Demand is climbing as the growing global burden of Hepatitis E converges with rapid advancements in molecular testing technology. Diagnostic laboratories and hospitals are prioritizing faster, more sensitive detection methods, pushing Hepatitis E diagnostic test adoption across regions where sanitation challenges and water contamination keep infection rates elevated. Polaris analysts note that the market grew from USD 53.05 million in 2023 to USD 54.61 million in 2024, positioning the segment for steady growth through 2032, with hospitals emerging as the largest revenue contributor and point-of-care settings posting the fastest incremental gains.

Key Trends Shaping the Hepatitis E Diagnostic Tests Industry

Advancements in Diagnostic Technologies

Traditional serological methods are increasingly complemented by PCR-based assays and next-generation sequencing, which offer higher sensitivity and specificity for earlier detection of Hepatitis E virus infections, reflecting a broader technology advancement across the diagnostics space.

Expansion in Emerging Markets

Countries across Asia, Africa, and Latin America are investing in healthcare infrastructure and diagnostic capabilities to manage the higher prevalence of Hepatitis E in these regions, supported by government and international health organization initiatives that are reshaping the regulatory landscape for disease surveillance.

Integration of AI and Machine Learning

AI- and machine-learning-driven analysis is beginning to enhance diagnostic accuracy and speed, helping identify infection patterns that traditional methods can miss and informing a more data-driven market outlook for personalized disease management.

👉 Explore The Complete Comprehensive Report Here: https://www.polarismarketresearch.com/industry-analysis/hepatitis-e-diagnostic-tests-market

Market Segmentation: Breaking Down the Hepatitis E Diagnostic Tests Market

Polaris segments the Hepatitis E diagnostic tests market by test type, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Test Type

The ELISA HEV IgM Test segment led the market in 2023, favored for its reliability, cost-effectiveness, and ease of use in detecting acute Hepatitis E infection across clinical settings, particularly in developing regions with higher disease prevalence. The RT-PCR segment is projected to expand at the fastest CAGR through 2032, driven by rising demand for highly sensitive tools capable of detecting HEV RNA and identifying chronic infections that antibody-based tests may miss.

By End User

Hospitals remain the dominant end-use segment, owing to extensive infrastructure, advanced diagnostic equipment, and high patient volumes requiring acute-case management. The point-of-care segment is gaining share as the fastest-growing category, fueled by demand for convenient, rapid diagnostic solutions in remote and resource-limited settings, signaling where near-term search intent around point-of-care Hepatitis E testing is shifting.

By Region

North America held the largest share of the global market in 2023, supported by advanced healthcare infrastructure and significant diagnostic technology investment. Asia-Pacific is expected to register the fastest regional growth through 2032, led by China, India, and Japan, reflecting high disease prevalence, large populations, and improving healthcare systems.

Regional Outlook: Where Is the Hepatitis E Diagnostic Tests Market Growing Fastest?

North America and Europe led the market on the back of advanced healthcare infrastructure, high awareness, and strong regulatory frameworks, while Asia-Pacific is expected to post the fastest CAGR through 2032, driven by high disease prevalence and expanding diagnostic access. Within North America, the United States remains the largest single market; within Asia-Pacific, China, India, and Japan are the primary growth engines. Europe rounds out the top regions, supported by public health campaigns and collaborations between public health institutions and private diagnostics companies.

👉 Explore the Full Hepatitis E Diagnostic Tests Market Report: https://www.polarismarketresearch.com/industry-analysis/hepatitis-e-diagnostic-tests-market

Competitive Landscape: Leading Hepatitis E Diagnostic Tests Companies

Key players profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific, DiaSorin S.p.A., PerkinElmer Inc., QIAGEN N.V., bioMérieux SA, Merck KGaA, Ortho Clinical Diagnostics, InBios International, Altona Diagnostics, Luminex Corporation, and Randox Laboratories, who are focusing on R&D investment, product innovation, and strategic partnerships to strengthen their position across the ELISA HEV IgM and hospital-led segments outlined above. Recent moves include Roche's November 2023 launch of its Elecsys Anti-HEV IgM and Anti-HEV IgG automated immunoassays, and the World Health Organization's inclusion of HEV tests such as the Altona assay in its Essential Diagnostics List that same month, both aimed at deepening diagnostic access across North America, Europe, and Asia-Pacific.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the Hepatitis E diagnostic tests space, this report benchmarks market share, segment-level pricing, and forecast data by test type, end user, and region to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking point-of-care diagnostics as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

Ev Charging Cables Market

Generative AI in Animation Market

Restaurant Management Software Market

Cell & Gene Therapy Bioanalytical Testing Services Market

Generative AI in Animation Market

Substation Automation Market

Dental Fluoride Treatment Market

Marine Hatch Covers Market: Efficacious and Economical Service for Meeting the Demands of Diverse Cargo Vessels

E-Fuel Market